경제
중도 성향
Pfizer's experimental lung cancer drug fails to extend survival in late-stage trial
Quartz
조회 0
.jpg)
이 뉴스, 어떠셨어요?
한 번의 탭으로 반응을 남겨요 · 로그인 불필요
The drug, acquired in Pfizer's $43 billion purchase of Seagen, did not outlast standard chemotherapy in a 703-patient study ...
관련 뉴스
2건 · 2개 매체중도 성향 100%
2개 매체
관련 뉴스 제보는 로그인 후 가능합니다.
'economy' 카테고리 뉴스
Toyota to slash even more output abroad as Iran war crimps demand
Nikkei Asia
Cursor’s 25-year-old CEO turned a Discord server into a talent pipeline to build his $60 billion SpaceX-backed AI company
Fortune
For the first time ever, no young women in England died of cervical cancer. In the U.S., RFK Jr.’s vaccine skepticism stalls HPV progress
Fortune